Dedifferentiated and undifferentiated ovarian carcinomas (DDOC/UDOC) are rare neoplasms defined by the presence of an undifferentiated carcinoma. In this study, we detailed the clinical, pathological, immunohistochemical, and molecular features of a series of DDOC/UDOC. We collected a multi-institutional cohort of 23 DDOC/UDOC and performed immunohistochemistry for core switch/sucrose nonfermentable (SWI/SNF) complex proteins (ARID1A, ARID1B, SMARCA4, and SMARCB1), mismatch repair (MMR) proteins, and p53. Array-based genome-wide DNA methylation and copy number variation analyses were performed on a subset of cases with comparison made to a previously reported cohort of undifferentiated endometrial carcinoma (UDEC), small cell carcinoma of the ovary, hypercalcemic type (SCCOHT), and tubo-ovarian high-grade serous carcinoma (HGSC). The age of all 23 patients with DDOC/UDOC ranged between 22 and 71 years (with an average age of 50 years), and a majority of them presented with extraovarian disease (16/23). Clinical follow-up was available for 19 patients. Except for 2 patients, the remaining 17 patients died from disease, with rapid disease progression resulting in mortality within a year in stage II-IV settings (median disease-specific survival of 3 months). Eighteen of 22 cases with interpretable immunohistochemistry results showed loss of expression of core SWI/SNF protein(s) that are expected to result in SWI/SNF complex inactivation as 10 exhibited coloss of ARID1A and ARID1B, 7 loss of SMARCA4, and 1 loss of SMARCB1. Six of 23 cases were MMR-deficient. Two of 20 cases exhibited mutation-type p53 immunoreactivity. Methylation profiles showed coclustering of DDOC/UDOC with UDEC, which collectively were distinct from SCCOHT and HGSC. However, DDOC/UDOC showed an intermediate degree of copy number variation, which was slightly greater, compared with SCCOHT but much less compared with HGSC. Overall, DDOC/UDOC, like its endometrial counterpart, is highly aggressive and is characterized by frequent inactivation of core SWI/SNF complex proteins and MMR deficiency. Its molecular profile overlaps with UDEC while being distinct from SCCOHT and HGSC.

CCU Neuropathology German Cancer Center Heidelberg Germany

Department of Laboratory Medicine and Pathology University of Alberta Edmonton Alberta Canada

Department of Neuropathology University Hospital Heidelberg Heidelberg Germany

Department of Obstetrics and Gynecology University of Alberta Edmonton Alberta Canada

Department of Pathology 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Department of Pathology and Laboratory Medicine BC Cancer Vancouver British Columbia Canada

Department of Pathology and Laboratory Medicine McGill University Health Centre Montreal Quebec Canada

Department of Pathology and Laboratory Medicine University of Calgary Calgary Alberta Canada

Department of Pathology Belfast Health and Social Care Trust Belfast United Kingdom

Department of Pathology Brigham and Women's Hospital Boston Massachusetts

Department of Pathology King Edward Memorial Hospital Perth Australia

Departments of Human Genetics McGill University Montreal Quebec Canada

Institute of Pathology University of Heidelberg Heidelberg Germany

000      

00000naa a2200000 a 4500

001      

bmc24007811

003      

CZ-PrNML

005      

20240423160305.0

007      

ta

008      

240412s2024 xxu f 000 0|eng||

009      

AR

024    7_

$a 10.1016/j.modpat.2023.100374 $2 doi

035    __

$a (PubMed)37925057

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxu

100    1_

$a Tessier-Cloutier, Basile $u Department of Pathology and Laboratory Medicine, McGill University Health Centre, Montreal, Quebec, Canada

245    10

$a Dedifferentiated and Undifferentiated Ovarian Carcinoma: An Aggressive and Molecularly Distinct Ovarian Tumor Characterized by Frequent SWI/SNF Complex Inactivation / $c B. Tessier-Cloutier, FKF. Kommoss, DL. Kolin, K. Němejcová, D. Smith, J. Pors, CJR. Stewart, WG. McCluggage, WD. Foulkes, A. von Deimling, M. Köbel, CH. Lee

520    9_

$a Dedifferentiated and undifferentiated ovarian carcinomas (DDOC/UDOC) are rare neoplasms defined by the presence of an undifferentiated carcinoma. In this study, we detailed the clinical, pathological, immunohistochemical, and molecular features of a series of DDOC/UDOC. We collected a multi-institutional cohort of 23 DDOC/UDOC and performed immunohistochemistry for core switch/sucrose nonfermentable (SWI/SNF) complex proteins (ARID1A, ARID1B, SMARCA4, and SMARCB1), mismatch repair (MMR) proteins, and p53. Array-based genome-wide DNA methylation and copy number variation analyses were performed on a subset of cases with comparison made to a previously reported cohort of undifferentiated endometrial carcinoma (UDEC), small cell carcinoma of the ovary, hypercalcemic type (SCCOHT), and tubo-ovarian high-grade serous carcinoma (HGSC). The age of all 23 patients with DDOC/UDOC ranged between 22 and 71 years (with an average age of 50 years), and a majority of them presented with extraovarian disease (16/23). Clinical follow-up was available for 19 patients. Except for 2 patients, the remaining 17 patients died from disease, with rapid disease progression resulting in mortality within a year in stage II-IV settings (median disease-specific survival of 3 months). Eighteen of 22 cases with interpretable immunohistochemistry results showed loss of expression of core SWI/SNF protein(s) that are expected to result in SWI/SNF complex inactivation as 10 exhibited coloss of ARID1A and ARID1B, 7 loss of SMARCA4, and 1 loss of SMARCB1. Six of 23 cases were MMR-deficient. Two of 20 cases exhibited mutation-type p53 immunoreactivity. Methylation profiles showed coclustering of DDOC/UDOC with UDEC, which collectively were distinct from SCCOHT and HGSC. However, DDOC/UDOC showed an intermediate degree of copy number variation, which was slightly greater, compared with SCCOHT but much less compared with HGSC. Overall, DDOC/UDOC, like its endometrial counterpart, is highly aggressive and is characterized by frequent inactivation of core SWI/SNF complex proteins and MMR deficiency. Its molecular profile overlaps with UDEC while being distinct from SCCOHT and HGSC.

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a lidé $7 D006801

650    _2

$a lidé středního věku $7 D008875

650    _2

$a mladý dospělý $7 D055815

650    _2

$a dospělí $7 D000328

650    _2

$a senioři $7 D000368

650    _2

$a nádorový supresorový protein p53 $x genetika $7 D016159

650    _2

$a variabilita počtu kopií segmentů DNA $7 D056915

650    12

$a nádory vaječníků $x genetika $x patologie $7 D010051

650    12

$a karcinom $x patologie $7 D002277

650    _2

$a epiteliální ovariální karcinom $7 D000077216

650    12

$a nádory endometria $x patologie $7 D016889

650    12

$a malobuněčný karcinom $7 D018288

650    _2

$a nádorové biomarkery $x genetika $x metabolismus $7 D014408

650    _2

$a DNA-helikasy $x genetika $x metabolismus $7 D004265

650    _2

$a jaderné proteiny $x genetika $7 D009687

650    _2

$a transkripční faktory $x genetika $x metabolismus $7 D014157

650    12

$a nádory mozku $7 D001932

650    12

$a dědičné nádorové syndromy $7 D009386

650    12

$a kolorektální nádory $7 D015179

655    _2

$a časopisecké články $7 D016428

700    1_

$a Kommoss, Felix K F $u Institute of Pathology, University of Heidelberg, Heidelberg, Germany

700    1_

$a Kolin, David L $u Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts

700    1_

$a Němejcová, Kristýna $u Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic

700    1_

$a Smith, DuPreez $u Department of Obstetrics and Gynecology, University of Alberta, Edmonton, Alberta, Canada

700    1_

$a Pors, Jennifer $u Department of Pathology and Laboratory Medicine, BC Cancer, Vancouver, British Columbia, Canada

700    1_

$a Stewart, Colin J R $u Department of Pathology, King Edward Memorial Hospital, Perth, Australia

700    1_

$a McCluggage, W Glenn $u Department of Pathology, Belfast Health and Social Care Trust, Belfast, United Kingdom

700    1_

$a Foulkes, William D $u Departments of Human Genetics, McGill University, Montreal, Quebec, Canada

700    1_

$a von Deimling, Andreas $u Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany; CCU Neuropathology, German Cancer Center (DKFZ), Heidelberg, Germany

700    1_

$a Köbel, Martin $u Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada

700    1_

$a Lee, Cheng-Han $u Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada. Electronic address: chlee2@ualberta.ca

773    0_

$w MED00003380 $t Modern pathology $x 1530-0285 $g Roč. 37, č. 1 (2024), s. 100374

856    41

$u https://pubmed.ncbi.nlm.nih.gov/37925057 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y - $z 0

990    __

$a 20240412 $b ABA008

991    __

$a 20240423160302 $b ABA008

999    __

$a ok $b bmc $g 2081669 $s 1217578

BAS    __

$a 3

BAS    __

$a PreBMC-MEDLINE

BMC    __

$a 2024 $b 37 $c 1 $d 100374 $e 20231103 $i 1530-0285 $m Modern pathology $n Mod Pathol $x MED00003380

LZP    __

$a Pubmed-20240412